CONTACT US   |  (864) 397-5101

SCbio Names 11 Life Science Leaders from Across Palmetto State to Board


Fiduciary and Operations Board members span state and industry segments, provide unique blend of expertise to lead for fast-growing industry

SOUTH CAROLINA – March 27, 2023 – Five years after undertaking a complete relaunch of the state’s official life sciences organization, SCbio has more than tripled its membership, increased revenues nine-fold, and had life sciences recognized as South Carolina’s fastest-growing industry. It has documented an industry presence in 42 of the state’s 46 counties while providing an annual economic impact of nearly $26 billion.

Now the organization has revamped its leadership structure to create an executive-led Fiduciary & Operations Board to lead the organization and industry to even greater heights, certain that the best and most exciting days for the industry and organization are ahead of it.

“In a state well-known for building BMWs, Boeing Dreamliners and Michelin tires, South Carolina’s life sciences story is booming as well, creating exciting opportunities to diversify and accelerate growth of our knowledge economy,” said James Chappell, President & CEO of SCbio in announcing the new board.  He cited rapid growth of such national and global brands as Nephron Pharmaceuticals, Arthrex, GE Health, Thermo Fisher, Abbott, AVX and Charles River as just a few examples of the state’s rapid rise in the life sciences industry, which currently spans more than 1,030 companies in 42 counties and employs over 87,700 well-paid associates directly or indirectly.

Leading fiduciary and operational efforts of the SCbio Board of Directors are:

David Stefanich, Founder & CEO of Rymedi, as Board Chair;

Lou Kennedy, CEO & Owner of Nephron Pharmaceuticals as Past Chair;

Christopher Hanson, Partner with Nelson Mullins, as Vice Chair;

Dan Nodes, COO of Vikor Scientific as Treasurer; and

Matthew Cannon, Dean for Edward Via College of Osteopathic Medicine-Carolinas, Secretary

Officers named to the Board are Greg Marshall, Corporate Vice President & General Manager of Charles River Labs; Thornton Kirby, CEO of SC Hospital Association; Cynthia Young, Ph.D., Dean of Clemson University College of Science; Ashely Teasdel, Deputy Secretary, SC Dept. of Commerce; Herbert Drayton, Managing Partner of HI Mark Capital; and Scott Pancoast, CEO & Founder of Zylö Therapeutics.  Mr. Chappell also serves on the Board.

Operating separately from the Fiduciary & Operational Board is a Strategic Advisory Board comprised of four working groups:  Workforce, Economic Development, Innovation & Patient Outcomes, and Policy/ Legislative.  Approximately 25 additional life science industry leaders from across the state are members of SCbio’s Strategic Advisory Board, charged with helping to shape strategic initiatives and to offer insights and expertise to advance the non-profit organization and industry.

A $25.7 billion annual industry in South Carolina and growing faster than in any other Southeastern state, SCbio is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has more than 1,000 firms directly involved in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental, and agricultural biotechnology products. 

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.